Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome

Rituximab (RTX) is a murine–human chimeric monoclonal antibody against CD20 that has been proven effective for preventing relapse in frequently-relapsing or steroid-dependent nephrotic syndrome (NS). Serum sickness, a type-3 hypersensitivity reaction resulting from injection of foreign proteins, has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CEN Case Rep
Autors principals: Nakamura, Misako, Kanda, Shoichiro, Yoshioka, Yuya, Takahashi, Chie, Owada, Keiho, Kajiho, Yuko, Harita, Yutaka, Oka, Akira
Format: Artigo
Idioma:Inglês
Publicat: Springer Singapore 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7148389/
https://ncbi.nlm.nih.gov/pubmed/31970629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13730-020-00449-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars